Transcriptional analysis of an E2F gene signature as a biomarker of activity of the cyclin-dependent kinase inhibitor PHA-793887 in tumor and skin biopsies from a phase I clinical study

ABSTRACT: Microarray analysis of transcriptional changes in biopsies of solid tumors from patients treated in a Phase I study with the Cdk inhibitor PHA-793887. 7 patient biopsies pre- and post-treatment in dye swap. Tumors are of different origins, and are described in the accompanying manuscript.

ORGANISM(S): Homo sapiens

SUBMITTER: JC Soria 

PROVIDER: E-GEOD-18553 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress